Literature DB >> 1451262

Parallel cardiac and vascular adaptation in hypertension.

M J Roman1, P S Saba, R Pini, M Spitzer, T G Pickering, S Rosen, M H Alderman, R B Devereux.   

Abstract

BACKGROUND: Although vascular damage in the noncoronary circulation is a major cause of complications in hypertension, relatively little is known of the in vivo geometry and function of the arterial circulation in patients with uncomplicated hypertension or of their relation to left ventricular hypertrophy, a marker of enhanced risk of cardiovascular complications. METHODS AND
RESULTS: Wall thickness and internal diameter of the common carotid artery and the presence of atherosclerosis within the extracranial carotid arteries were determined by ultrasound in 43 asymptomatic hypertensive patients and 43 normotensive subjects matched for sex, age, and body size. Vascular stiffness was estimated from simultaneous superimposed carotid pressure waveforms obtained with an external solid-state transducer. Left ventricular size and function were determined echocardiographically. Compared with normal subjects, hypertensive patients had greater left ventricular absolute and relative wall thicknesses, left ventricular mass, and carotid absolute and relative wall thicknesses (p < 0.005). Carotid intimal-medial thickness exceeded the 95th percentile of normal values in 28% of hypertensive patients (p < 0.01). Carotid atherosclerosis was equally prevalent within the two blood pressure groups and was associated with older age, larger left ventricular and carotid wall thicknesses, and carotid diameter. Despite similar carotid pulse pressures, vascular stiffness was significantly increased in the hypertensive patients. Among the population as a whole, significant relations existed between cardiac and vascular wall thicknesses and internal dimensions. In multivariate analyses, these relations were statistically independent of age and blood pressure.
CONCLUSIONS: The present study documents the presence of geometric and functional changes within the common carotid artery in uncomplicated hypertension that parallel findings within the left ventricle. The potential contribution of these changes to the cardiovascular complications of hypertension, particularly in the setting of left ventricular hypertrophy, is unknown.

Entities:  

Mesh:

Year:  1992        PMID: 1451262     DOI: 10.1161/01.cir.86.6.1909

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  48 in total

1.  Preclinical cardiac disease in nonalcoholic fatty liver disease with and without metabolic syndrome.

Authors:  Jasbir Makker; Hassan Tariq; Jonathan N Bella; Kishore Kumar; Chukwunonso Chime; Harish Patel; Muhammad Umar Kamal; Danial Shaikh; Vamshidhar Vootla; Bharat Bajantri; Umut Gomceli; Mohammad Alshelleh; Richard Peralta; Aiyi Zhang; Sridhar Chilimuri
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

2.  Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.

Authors:  Richard Sherva; Charles E Ford; John H Eckfeldt; Barry R Davis; Eric Boerwinkle; Donna K Arnett
Journal:  Stroke       Date:  2010-12-23       Impact factor: 7.914

3.  Vascular biomarkers in the prediction of clinical cardiovascular disease: the Strong Heart Study.

Authors:  Mary J Roman; Jorge R Kizer; Lyle G Best; Elisa T Lee; Barbara V Howard; Nawar M Shara; Richard B Devereux
Journal:  Hypertension       Date:  2011-11-07       Impact factor: 10.190

4.  Reduced ventricular flow propagation velocity in elite athletes is augmented with the resumption of exercise training.

Authors:  Louise H Naylor; Leonard F Arnolda; Jenny A Deague; David Playford; Antonio Maurogiovanni; Gerard O'Driscoll; Daniel J Green
Journal:  J Physiol       Date:  2005-01-20       Impact factor: 5.182

5.  Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity.

Authors:  Baris Yilmazer; Tayfun Sahin; Berrin Öztaş Unlu; Hale Maral Kir; Ayse Cefle
Journal:  Rheumatol Int       Date:  2015-02-11       Impact factor: 2.631

6.  Arterial haemodynamics on ventricular hypertrophy in rats with simulated aortic stiffness.

Authors:  Hsing I Chen; Nan-Kuang Hsieh; Huai-Ren Chang; Cheng-Tao Hu
Journal:  Pflugers Arch       Date:  2007-09-15       Impact factor: 3.657

7.  Echocardiographic left ventricular mass index predicts incident stroke in African Americans: Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Ervin R Fox; Nabhan Alnabhan; Alan D Penman; Kenneth R Butler; Herman A Taylor; Thomas N Skelton; Thomas H Mosley
Journal:  Stroke       Date:  2007-08-30       Impact factor: 7.914

8.  Leukotriene haplotype × diet interaction on carotid artery hypertrophy and atherosclerosis in American Indians: the Strong Heart Family Study.

Authors:  Jinying Zhao; Mary J Roman; Richard B Devereux; Fawn Yeh; Ying Zhang; Karin Haack; Lyle G Best; Shelley A Cole; Elisa T Lee; Barbara V Howard
Journal:  Atherosclerosis       Date:  2014-01-10       Impact factor: 5.162

9.  Lack of associations of ten candidate coronary heart disease risk genetic variants and subclinical atherosclerosis in four US populations: the Population Architecture using Genomics and Epidemiology (PAGE) study.

Authors:  Lili Zhang; Petra Buzkova; Christina L Wassel; Mary J Roman; Kari E North; Dana C Crawford; Jonathan Boston; Kristin D Brown-Gentry; Shelley A Cole; Ewa Deelman; Robert Goodloe; Sarah Wilson; Gerardo Heiss; Nancy S Jenny; Neal W Jorgensen; Tara C Matise; Bob E McClellan; Alejandro Q Nato; Marylyn D Ritchie; Nora Franceschini; W H Linda Kao
Journal:  Atherosclerosis       Date:  2013-03-13       Impact factor: 5.162

Review 10.  Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension.

Authors:  Isola A M Brown; Lukas Diederich; Miranda E Good; Leon J DeLalio; Sara A Murphy; Miriam M Cortese-Krott; Jennifer L Hall; Thu H Le; Brant E Isakson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.